AU2002348020A1 - Tyrosine kinase inhibitors - Google Patents
Tyrosine kinase inhibitorsInfo
- Publication number
- AU2002348020A1 AU2002348020A1 AU2002348020A AU2002348020A AU2002348020A1 AU 2002348020 A1 AU2002348020 A1 AU 2002348020A1 AU 2002348020 A AU2002348020 A AU 2002348020A AU 2002348020 A AU2002348020 A AU 2002348020A AU 2002348020 A1 AU2002348020 A1 AU 2002348020A1
- Authority
- AU
- Australia
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- inhibitors
- tyrosine
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34290001P | 2001-10-25 | 2001-10-25 | |
| US60/342,900 | 2001-10-25 | ||
| PCT/US2002/033921 WO2003035616A2 (fr) | 2001-10-25 | 2002-10-21 | Inhibiteurs de la tyrosine kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002348020A1 true AU2002348020A1 (en) | 2003-05-06 |
Family
ID=23343769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002348020A Abandoned AU2002348020A1 (en) | 2001-10-25 | 2002-10-21 | Tyrosine kinase inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002348020A1 (fr) |
| WO (1) | WO2003035616A2 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1829507A (zh) * | 2003-07-24 | 2006-09-06 | 麦克公司 | 酪氨酸激酶抑制剂 |
| EP2372363A1 (fr) | 2005-09-20 | 2011-10-05 | OSI Pharmaceuticals, Inc. | Marqueurs biologiques prédictifs d'une réaction anticancéreuse aux inhibiteurs kinase du récepteur du facteur de croissance 1 analogue à l'insuline |
| EP2400985A2 (fr) | 2009-02-25 | 2012-01-04 | OSI Pharmaceuticals, LLC | Thérapie anti-cancer combinée |
| JP2012519170A (ja) | 2009-02-26 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 生体内の腫瘍細胞のｅｍｔステータスをモニターするためのｉｎｓｉｔｕ法 |
| WO2010099364A2 (fr) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Méthodes d'identification d'agents qui inhibent les cellules cancéreuses mésenchymateuses ou leur formation |
| JP2012519281A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
| WO2010099138A2 (fr) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Procédés pour l'identification d'agents qui inhibent les cellules tumorales de type mésenchymateuses ou leur formation |
| US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
| JP2013520998A (ja) | 2010-03-03 | 2013-06-10 | オーエスアイ・ファーマシューティカルズ，エルエルシー | インスリン様増殖因子−１受容体キナーゼ阻害剤に対する抗癌反応の予測に役立つ生物学的マーカー |
| AU2011223643A1 (en) | 2010-03-03 | 2012-06-28 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| WO2011112666A1 (fr) | 2010-03-09 | 2011-09-15 | OSI Pharmaceuticals, LLC | Thérapie anticancéreuse combinatoire |
| US20120214830A1 (en) | 2011-02-22 | 2012-08-23 | OSI Pharmaceuticals, LLC | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma |
| EP2702173A1 (fr) | 2011-04-25 | 2014-03-05 | OSI Pharmaceuticals, LLC | Utilisation de signatures de gènes de tem dans la découverte de médicaments contre le cancer, diagnostics et traitement du cancer |
| WO2013152252A1 (fr) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Polythérapie antinéoplasique |
| JP6255038B2 (ja) | 2013-02-26 | 2017-12-27 | トリアクト セラピューティクス，インク． | 癌治療 |
| US9381246B2 (en) | 2013-09-09 | 2016-07-05 | Triact Therapeutics, Inc. | Cancer therapy |
| CN104961669B (zh) * | 2015-03-18 | 2018-02-13 | 河南农业大学 | N‑烃基‑2‑甲基‑5‑甲酰基‑3‑吡咯甲酸酯的制备方法及其在卷烟加香中的应用 |
| US11161823B2 (en) | 2019-03-11 | 2021-11-02 | National Guard Health Affairs | Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1139754A4 (fr) * | 1998-12-31 | 2002-12-18 | Sugen Inc | Composes 3-heteroarylidenyl-2-indolinone utilises pour modulation de l'activite de la proteine kinase et dans la chimiotherapie du cancer |
-
2002
- 2002-10-21 AU AU2002348020A patent/AU2002348020A1/en not_active Abandoned
- 2002-10-21 WO PCT/US2002/033921 patent/WO2003035616A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003035616A3 (fr) | 2003-10-23 |
| WO2003035616A2 (fr) | 2003-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002361577A1 (en) | Tyrosine kinase inhibitors | |
| AU2002334355A1 (en) | Protein tyrosine kinase inhibitors | |
| AU2003299651A1 (en) | Tyrosine kinase inhibitors | |
| EP1381598A4 (fr) | Nouveaux inhibiteurs de la tyrosine kinase | |
| AU2003298942A1 (en) | Tyrosine kinase inhibitors | |
| AU2001237041A1 (en) | Kinase inhibitors | |
| AU2003282891A1 (en) | Novel tyrosine kinases inhibitors | |
| AU2000240570A1 (en) | Pyrrolopyrimidines as tyrosine kinase inhibitors | |
| AU2002305260A1 (en) | Pyrazole derived kinase inhibitors | |
| AU2002348394A1 (en) | Tyrosine kinase inhibitors | |
| AU2437900A (en) | Piperidinylquinolines as protein tyrosine kinase inhibitors | |
| AU2003275282A1 (en) | Novel tyrosine kinase inhibitors | |
| AU2002357193A1 (en) | Thienopyrimidine compounds as protein tyrosine kinase inhibitors | |
| AU2002348020A1 (en) | Tyrosine kinase inhibitors | |
| AU2002348393A1 (en) | Tyrosine kinase inhibitors | |
| AU2002323406A1 (en) | Tyrosine kinase inhibitors | |
| AU2001241917A1 (en) | Myt1 kinase inhibitors | |
| AU2002327534A1 (en) | Tyrosine kinase inhibitors | |
| AU2002253350A1 (en) | 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors | |
| AU2002322568A1 (en) | Tyrosine kinase inhibitors | |
| AU2002327342A1 (en) | Tyrosine kinase inhibitors | |
| AU2002355733A1 (en) | Tyrosine kinase inhibitors | |
| AU2002327619A1 (en) | Tyrosine kinase inhibitors | |
| AU2002326466A1 (en) | Tyrosine kinase inhibitors | |
| AU2002304001A1 (en) | Tyrosine kinase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |